Leading in Cardiovascular
Tissue Engineering

We are a biotechnology company focussing on the development and manufacturing of biological medical devices. Our cell-free implants minimize the need for long-term medication, which helps to reduce possible negative side effects. This can significantly improve the quality of life, especially for younger patients.
More Than
0
Years in Business
Available in
0
Countries
More than
14000
Implants Worldwide

Technology

Auto Tissue Berlin uses a proprietary and patented glutaraldehyde-free process to decellularize and sterilize the biological tissue. Decellularized tissue has repeatedly proven to be superior to glutaraldehyde-treated tissue in terms of durability, especially in children.
Read more...

Contract Manufacturing

Auto Tissue Berlin also offers contract research and manufacturing services for all types of biological tissue, and supports engineering, design and prototyping of cardiovascular devices.

Read more...

Products

The Matrix Patch™ is a cell-free equine pericardial patch for vascular reconstruction and cardiac defect repair. It is primarily used in pediatric cardiac surgery and for valve repair in adults.

Read more...

Latest News

April 17, 2023

Start of direct sales in Spain

With immediate effect, we are ending the business relationship with Mercé V. Electromedicina, Valencia, Spain. Our products are now available via direct sales.

Read more  

February 8, 2023

Round Table Meeting Berlin 2023

A round table meeting with eight surgeons from Mexico took place on February 4, 2023 in the Mercure Hotel Berlin Mitte.

Read more  

November 7, 2022

New publication: Mid-term performance of decellularized equine pericardium in congenital heart surgery

Viktoria WM Weixler from the German Heart Center Berlin published today a new report on the mid-term performance of decellularized equine pericardium in congenital heart surgery.

Read more